Genworth Financial (GNW) has rolled out a new Family Caregiver Benefit that lets eligible long term care policyholders in certain states direct coverage toward qualified care provided by relatives.
Recent price action for Genworth Financial has been choppy, with a 1-day share price return of 3.79% after the Family Caregiver Benefit news, set against a 30-day share price return down 6.9% and a 1-year total shareholder return of 4.61%. The 5-year total shareholder return of 127.63% points to much stronger longer term momentum.
Spot opportunities in other insurers adapting to aging and caregiving trends by scanning our hand picked list of solid balance sheet and fundamentals (25 results).Bulls point to a $3.4b insurer earning $202m and leaning into caregiving trends. Bears see choppy returns and legacy long term care risk. Which side does Genworth Financial’s current valuation reward?
Valuation for Genworth Financial comes back to what investors are willing to pay for its earnings. At a last close of $9.31, the stock trades on a P/E of 17.4x, which sits close to the broader US market multiple but well above many insurance peers.
The P/E ratio compares the current share price to earnings per share. For a financial group like Genworth Financial, that figure reflects what the market is paying today for each dollar of profit from its mortgage insurance and long term care focused operations.
That multiple sits just under the US market average of 17.8x, so on a headline view the stock is not being priced at an extreme premium to the wider market. The context changes when you look at the sector. The US insurance industry trades at 10.6x and the peer group at 9.8x, which is materially lower. With earnings declining 3.3% over the past year and a 5 year annual profit decline of 40.5%, the current P/E requires investors to accept a richer tag than the typical insurer without clear evidence in this data set of faster earnings growth to match.
Compared with peers, Genworth Financial is being valued far more expensively on earnings. The stock is described as "expensive" versus both the sector and peer averages, and there is no fair P/E ratio estimate available from the SWS model that might indicate a level the valuation could move toward.
See what the numbers say about this price — find out in our valuation breakdown.
Result: Price-to-earnings of 17.4x (OVERVALUED)
Still, Genworth Financial faces pressure from legacy long term care exposures, and any earnings disappointment could quickly challenge a 17.4x P/E that already exceeds insurance peers.
Find out about the key risks to this Genworth Financial narrative.
Mixed signals on Genworth Financial so far. If you want to move quickly and build your own stance, start with its 1 key reward and 2 important warning signs.
If Genworth Financial has sharpened your focus on valuation and risk, do not stop here. Broader idea hunting across high quality filters can surface setups you might otherwise miss.
Use the Simply Wall Street Screener to pressure test your next moves before capital is on the line.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com